Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14970054 | 0.79 | HSD17B10 (0.33) | USP2ALOX15APOBEC3AHSD17B10APOBEC3G | |
| SCHEMBL1673946 | 0.76 | USP2 (0.32) | USP2ALOX15APOBEC3AHSD17B10APOBEC3G | |
| SCHEMBL2666806 | 0.76 | HPGD (0.31) | HSD17B10 | |
| SCHEMBL31696345 | 0.76 | USP2 (0.32) | USP2ALOX15APOBEC3AHSD17B10APOBEC3G | |
| SCHEMBL20048890 | 0.73 | USP2 (0.30) | USP2ALOX15APOBEC3AHSD17B10APOBEC3G | |
| SCHEMBL16268335 | 0.73 | USP2 (0.33) | USP2ALOX15APOBEC3AHSD17B10APOBEC3G | |
| SCHEMBL6844986 | 0.73 | KDM4E (0.34) | USP2ALOX15APOBEC3AHSD17B10APOBEC3G | |
| SCHEMBL17339855 | 0.70 | HSD17B10 (0.35) | USP2ALOX15APOBEC3AHSD17B10APOBEC3G | |
| SCHEMBL814058 | 0.70 | HSD17B10 (0.33) | USP2ALOX15APOBEC3AHSD17B10APOBEC3G | |
| SCHEMBL20049334 | 0.69 | IKBKB (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009131926-A1 | QUINUCLIDINE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-10-29 | — | — | WO | disclosed |